Your browser doesn't support javascript.
loading
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.
Mark, M; Rusakiewicz, S; Früh, M; Hayoz, S; Grosso, F; Pless, M; Zucali, P; Ceresoli, G L; Maconi, A; Schneider, M; Froesch, P; Tarussio, D; Benedetti, F; Dagher, J; Kandalaft, L; von Moos, R; Tissot-Renaud, S; Schmid, S; Metaxas, Y.
Afiliação
  • Mark M; Department of Oncology/Haematology, Kantonsspital Graubünden, Chur, Switzerland. Electronic address: michael.mark@ksgr.ch.
  • Rusakiewicz S; Center of Experimental Therapeutics, Department of Oncology UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland; Department of Oncology, UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • Früh M; Department of Medical Oncology and Haematology, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Department of Medical Oncology, University of Bern, Bern, Switzerland.
  • Hayoz S; SAKK Coordinating Centre, Bern, Switzerland.
  • Grosso F; Mesothelioma Unit e Oncology, SS. Antonio and C. Arrigo Hospital, Alessandria, Italy.
  • Pless M; Department of Medical Oncology and Haematology, Kantonsspital Winterthur, Winterthur, Switzerland.
  • Zucali P; Department of Biomedical Sciences, Humanitas University, Milan, Italy; Department of Oncology, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Ceresoli GL; Oncology Unit, Humanitas Gavazzeni Clinic, Bergamo, Italy.
  • Maconi A; Research Training Innovation Infrastructure, Research Innovation Department, Azienda Ospedaliera "SS Antonio e Biagio e Cesare Arrigo", Alessandria, Italy.
  • Schneider M; SAKK Coordinating Centre, Bern, Switzerland.
  • Froesch P; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Tarussio D; Center of Experimental Therapeutics, Department of Oncology UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland; Department of Oncology, UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • Benedetti F; Center of Experimental Therapeutics, Department of Oncology UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland; Department of Oncology, UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • Dagher J; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
  • Kandalaft L; Center of Experimental Therapeutics, Department of Oncology UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland; Department of Oncology, UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • von Moos R; Department of Oncology/Haematology, Kantonsspital Graubünden, Chur, Switzerland.
  • Tissot-Renaud S; Center of Experimental Therapeutics, Department of Oncology UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland; Department of Oncology, UNIL CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • Schmid S; Department of Medical Oncology and Haematology, St. Gallen, Switzerland; University of Bern, Bern, Switzerland.
  • Metaxas Y; Department of Haematology and Oncology, Kantonsspital Münsterlingen, Münsterlingen, Switzerland.
ESMO Open ; 7(3): 100446, 2022 06.
Article em En | MEDLINE | ID: mdl-35427834
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mesotelioma Maligno / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mesotelioma Maligno / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido